Cytochrome P450 17A1 Inhibitor
34 drugs across 17 manufacturers|33 Generic,1 Brand
The Cytochrome P450 17A1 Inhibitor class contains 34 NDCs from 17 manufacturers (33 generic, 1 brand), at an average NADAC of $4.16 per unit. Every drug, manufacturer, and price in this FDA-defined pharmacologic class is listed below.
Total Drugs
34
33G / 1B
Manufacturers
17
Avg $4.1564/unit
Avg 7d Change
-2.84%
Across 33 drugs with changes
7d Activity
of 34 total drugs
Class Price Trend
Monthly average NADAC price per unit, split by generic and brand
Frequently Asked Questions
How many drugs are in the Cytochrome P450 17A1 Inhibitor class?
The Cytochrome P450 17A1 Inhibitor class contains 34 NDCs from 17 manufacturers — 33 generic and 1 brand product.
What is the average price of Cytochrome P450 17A1 Inhibitor drugs?
The average NADAC for the Cytochrome P450 17A1 Inhibitor class is $4.1564 per unit across 34 NDCs.
Is generic cheaper than brand in the Cytochrome P450 17A1 Inhibitor class?
The average generic NADAC in this class is $1.6270 per unit, versus $87.6254 for brand — generic is about 98% cheaper on average.
Which manufacturers make Cytochrome P450 17A1 Inhibitor drugs?
17 manufacturers make drugs in the Cytochrome P450 17A1 Inhibitor class. Ranked by number of NDCs, the largest are Amneal Pharmaceuticals NY LLC (4), Dr. Reddy's Laboratories Inc. (3), Novadoz Pharmaceuticals LLC (3), NorthStar Rx LLC (3), Mylan Pharmaceuticals Inc. (2).
How has Cytochrome P450 17A1 Inhibitor pricing changed recently?
Over the past 7 days, 0 NDCs in this class rose and 33 fell, with a class-wide average change of -2.8%.
Manufacturer Breakdown
17 manufacturers producing drugs in this therapeutic class(1 pricing outlier)
and 5 more manufacturers